Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Diagnostic Study of European and Japanese Advanced NSCLC Patients to Evaluate Suitable Sample Types for EGFR Testing,

NCT01785888 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01785888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01785888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Diagnostic Study of European and Japanese Advanced NSCLC Patients to Evaluate Suitable Sample Types for EGFR Testing,
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
April 30, 2014
Enrollment
1,311 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

egfr mutation status in ansclc patients (locally advanced and/or metastatic disease) with adenocarcinoma and non-adenocarcinoma histologies.